Erste Asset Management’s bluebird bio BLUE Stock Holding History

Erste Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-750	Closed	-$156K	–	556
2021 Q4	$156K	Sell	750 -408	-35%	-$96.3K	﹤0.01%	499
2021 Q3	$285K	Hold	1,158	–	–	0.01%	456
2021 Q2	$451K	Hold	1,158	–	–	0.01%	427
2021 Q1	$429K	Sell	1,158 -1,586	-58%	-$781K	0.01%	396
2020 Q4	$1.57M	Hold	2,744	–	–	0.04%	296
2020 Q3	$1.96M	Hold	2,744	–	–	0.07%	249
2020 Q2	$2.14M	Hold	2,744	–	–	0.09%	226
2020 Q1	$1.67M	Hold	2,744	–	–	0.1%	200
2019 Q4	$3.14M	Hold	2,744	–	–	0.14%	150
2019 Q3	$3.3M	Hold	2,744	–	–	0.18%	133
2019 Q2	$4.4M	Sell	2,744 -271	-9%	-$469K	0.23%	113
2019 Q1	$5.98M	Buy	3,015 +216	+8%	+$380K	0.33%	79
2018 Q4	$3.53M	Buy	+2,799	New	+$4.29M	0.24%	112

Other funds holding BLUE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Erste Asset Management's BLUE Position: Q1 2022 in Review

Erste Asset Management sold out of bluebird bio (BLUE) in Q1 2022, closing a stake of 750 shares — an estimated $156K sold.

Erste Asset Management first reported a position in BLUE in Q4 2018 and held it in 13 quarters. The position peaked at $5.98M in Q1 2019. 174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.

Erste Asset Management reported no remaining bluebird bio position as of Q1 2022 after selling out during the quarter.
Erste Asset Management sold 750 bluebird bio shares in Q1 2022, an estimated $156K.
Erste Asset Management first reported a position in bluebird bio in Q4 2018 and held it in 13 quarters.
Erste Asset Management's bluebird bio position peaked at $5.98M in Q1 2019.
174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.

Based on Erste Asset Management's 13F filing for Q1 2022, filed 25 Nov 2024.